BridgeMD
New treatment option for Pre Diabetic
Official title PREdiabetes GLycemic Impact and Data Evaluation
ClinicalTrials.gov ID: NCT07599072
What this study is testing
- What it's testing
- This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized tool that increases patient adherence to lifestyle changes compared to conventional SMBG methods.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age of 18 years and older.
- Presence of prediabetes diagnosed according to criteria of the American Diabetes Association
- Persons who treated with diet and exercise alone or metformin on a stabilized dose for at least 3 months before the study;
- Ability to comply with protocol requirements and maintain a patient diary.
- Signed informed consent.
You likely can't join if
- Presence of type 1 or type 2 diabetes;
- Decompensated liver or kidney diseases (GFR \< 45 ml/min/1. 73 m²);
- Active cardiovascular diseases within 12 months of Visit 1, such as myocardial infarction, clinically significant arrhythmia, unstable angina...
- Endocrine disorders (e.g., Itsenko-Cushing syndrome, acromegaly) that affect glycemia;
- Pregnancy or lactation;
- Mental or cognitive impairments that would interfere with study participation;
See the full eligibility criteria
- Age of 18 years and older.
- Presence of prediabetes diagnosed according to criteria of the American Diabetes Association
- Persons who treated with diet and exercise alone or metformin on a stabilized dose for at least 3 months before the study;
- Ability to comply with protocol requirements and maintain a patient diary.
- Signed informed consent.
- Presence of type 1 or type 2 diabetes;
- Decompensated liver or kidney diseases (GFR \< 45 ml/min/1. 73 m²);
- Active cardiovascular diseases within 12 months of Visit 1, such as myocardial infarction, clinically significant arrhythmia, unstable angina, coronary artery bypass surgery, or angioplasty; or are expected to require...
- Endocrine disorders (e.g., Itsenko-Cushing syndrome, acromegaly) that affect glycemia;
- Pregnancy or lactation;
- Mental or cognitive impairments that would interfere with study participation;
- Daily use of any form of steroid medication (oral, inhaled, injected) within the last 3 months;
- Recent use of any CGM within the last 12 months;
- Known allergy to sensor materials;
- Has evidence of current abuse of drugs or alcohol or a history of abuse that, in the investigator's opinion, would cause the individual to be noncompliant;
- Participation in another clinical study within the last 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Kyiv, Ukraine
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kyiv, Ukraine. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.